Use of granulocyte-macrophage colony-stimulating factor for reversal of neutropenia following combined kidney-pancreas transplantation.
Squiers
E C
EC
Department of Surgery, Ohio State University, USA.
Elkhammas
E A
EA
Henry
M L
ML
D000328:Adult; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000601:surgery; D003928:Diabetic Nephropathies / Q000150:complications / Q000601:surgery; D005260:Female; D006084:Graft Rejection / Q000209:etiology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology*; D016035:Pancreas Transplantation / Q000009:adverse effects*
D016178:Granulocyte-Macrophage Colony-Stimulating Factor